Proair respiclick is currently on the market for treatment of asthma. It is the only albuterol breath actuated dry powder inhaler on the market. Asthma patients may remember Maxair Autoinhaler (pirbuterol) which also was a breath actuated dry powder as well. But it was withdrawn from the market because they contained CFC’s (Chlorofluorcarbons), which are substances that harm the ozone layer above the earth. Many patients were very fond of Maxair as they responded better to the breath actuated device, they were withdrawn from the market at the end of 2013. But now with Proair respiclick, those patients can go back again to using albuterol as a rescue medication in a breath actuated device.
Proair respiclick is not for maintenance for asthma. But rather it is for rescue usage only and it is approved for 12 years of age and older. It was also given approval for exercise induced asthma.
Asthma is a chronic disease of inflammation and constriction of the large and small airways of the lungs. Asthma can be characterized by coughing, wheezing and shortness of breath. Without appropriate treatment, a person can develop an asthma attack that could lead to hospitalization or even death. All asthmatic patients should have access to albuterol. Albuterol can come in a nebulized form for infants and children. It is also available as a metered dose inhaler (Proair, Ventolin, Proventil). Proair Respiclick is a breath actuated device that is only activated when the patient inhales on the device. There are other breath actuated devices on the market for asthma besides proair respiclick, but they are not for rescue usage, they are for maintenance treatment only. Some of them are Advair, Asmanex and Breo.
Proair respiclick may not be for every asthma patient, as some patients may prefer the meter dose inhaler device. You should speak to your asthma doctor and discuss which medication is best for you.
Update May 9, 2016 : Proair respiclick was recently approved for a pediatric indication, children age 4 years and up can now use it.
